Health economics of kidney replacement therapy in Singapore: Taking stock and looking ahead.
Ann Acad Med Singap
; 51(4): 236-240, 2022 Apr.
Article
em En
| MEDLINE
| ID: mdl-35506407
The prevalence of end-stage kidney disease (ESKD) in Singapore remains high and continues to rise. We continue to face major challenges in containing the rising incidence of ESKD and providing sustainable kidney replacement therapy. Our cost projections provide an insight into the present and future, urging a call to action to augment existing initiatives to address the emergent issues.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Terapia de Substituição Renal
/
Falência Renal Crônica
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article